Implication of IZUMO2 in the cell‐in‐cell phenomenon: A potential therapeutic target for triple‐negative breast cancer

Abstract Background Triple‐negative breast cancer (TNBC) is characterized by the loss of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2. The aggressive clinicopathological features and resistance to currently available therapeutics of the disease warrant an ur...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Toshiya Higashi, Chiemi Saigo, Wakana Chikaishi, Hirokatsu Hayashi, Yuki Hanamatsu, Manabu Futamura, Nobuhisa Matsuhashi, Tamotsu Takeuchi
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2024-03-01
coleção:	Thoracic Cancer
Assuntos:	adiponectin‐expressing Tregs cell‐in‐cell activity IZUMO2 monoclonal antibody triple‐negative breast cancer
Acesso em linha:	https://doi.org/10.1111/1759-7714.15189
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!